+1-646-568-9980, +44-203-287-6050
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
breast cancer therapy market

Breast Cancer Therapy Market, [By Therapy Type (Targeted therapy, Chemotherapy, Surgery & Radiation Therapy, and Hormonal therapy); By Region]: Market Size & Forecast, 2018 – 2026

Published: Nov 2018
Pages: 115
Format: PDF
Report ID: PM1534
License and Pricing
Buy Now Inquire Before Buying

Report Summary

The global Breast Cancer Therapy Market was valued at USD 14.2 billion in 2017 and is anticipated to grow at a CAGR of 10.3% during the forecast period. Brest cancer is a type of cancer developing in the breast tissue. The common indication of breast cancer includes red patches and formation of lump in breast on the skin. Some of the risk factors for developing breast cancer are overexposure to radiation, obesity, lack of physical exercise, and high consumption of alcohol.

According to the reports of The National Cancer Institute approximately 246,660 cases of breast cancer were diagnosed during 2016. The rising prevalence rate and increasing occurrence of breast cancer are major factors boosting the global breast cancer therapies market growth. Currently, several breast cancer awareness programs for early detection and treatments are held in several emerging nations across Asia Pacific and Latin America which is further anticipated to generate the market opportunities in the market. It is believed that with such initiatives including early diagnosis and treatment, the demand for global breast cancer therapies is expected to increase along with factors such as pharmacology promoting drug development, high investment in R&D and advancements in oncology.

Global Breast Cancer Therapies Market Share, By Therapy Type, 2017 - 2026

Note: Inside circle depicts data for 2017 & outside circle depicts data for 2026

Segment Analysis

The global breast cancer therapies Market is segmented on the basis of therapy type and region. On the basis of therapy type, the market is categorized into targeted therapy, chemotherapy, surgery & radiation therapy, and hormonal therapy.

Regional Analysis

The Breast Cancer Therapies Market report comprises a detailed geographic distribution of the market across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa regions. North America is segmented into U.S., Canada, and Mexico. European region comprises of Germany, UK, France, and Italy. Asia-Pacific is further bifurcated into China, India, Japan. On the basis of geography, North America breast cancer therapies market is observed to hold the largest market share. The major factors responsible for the high market growth in this region includes high occurrence of breast cancer, growing government welfares and increasing female geriatric population base. In addition, strong demand of diagnostic tests and advancement in technology for the effective treatment of breast cancer are other factors marking the significant growth of breast caner therapies market in North America.

Sample Table
Global Breast Cancer Therapies Market, By Therapy Type, 2017 – 2026
(USD Billion)

Competitive Analysis

The leading players in the breast cancer therapies market include AstraZeneca, Bayer AG, Danaher, Bristol Myers Squibb, Eisai Co., Ltd., Merck & Co., Novartis AG, Novocure, Pfizer Inc., and F. Hoffmann-La Roche AG among others. The leading players in the market are introducing new innovative products in the market to cater to the growing consumer demands. Global players are entering new markets in developing regions to expand their customer base and strengthen market presence.

Key questions answered by the report

  • What is the current Market Size and Forecasts of Breast Cancer Therapies Market
  • What is the market opportunity for Breast Cancer Therapies Market by therapy type
  • How big is the market size for products in the Breast Cancer Therapies Market by therapy type
  • How much is the estimated market for Breast Cancer Therapies Market in North America during the forecast period
  • What are the companies in this market and how are they classified
  • What are the available opportunities and who are the top market players in this space

 Table of Contents

  1. Overview and Scope
    1. Research goal & scope
    2. Research assumptions
    3. Research Methodology
      1. Primary data sources
      2. Secondary data sources
    4. Key take-away
    5. Stakeholders
  2. Executive Summary
    1. Market Definition
    2. Market Segmentation
  3. Breast Cancer Therapies Market Insights
    1. Breast Cancer Therapies – Industry snapshot
    2. Breast Cancer Therapies - Ecosystem analysis
    3. Breast Cancer Therapies Market Dynamics
      1. Breast Cancer Therapies – Market Forces
        1. Breast Cancer Therapies Market Driver Analysis
        2. Breast Cancer Therapies Market Restraint/Challenges analysis
        3. Breast Cancer Therapies Market Opportunity Analysis
    4. Industry analysis - Porter's five force
      1. Bargaining power of supplier
      2. Bargaining power of buyer
      3. Threat of substitute
      4. Threat of new entrant
      5. Degree of competition
    5. Breast Cancer Therapies Market PEST Analysis, 2017
    6. Breast Cancer Therapies Market Value Chain Analysis
    7. Breast Cancer Therapies Industry Trends
    8. Competitive Ranking Analysis
  4. Breast Cancer Therapies Market Size and Forecast, 2017-2026 by Therapy type
    1. Key Findings
    2. Targeted therapy
    3. Chemotherapy
    4. Surgery & radiation therapy
    5. Hormonal therapy
  5. Breast Cancer Therapies Market Size and Forecast, 2017-2026 by Region
    1. Key Findings
    2. North America
      1. U.S.
      2. Canada
    3. Europe
      1. Germany
      2. UK
      3. France
    4. Asia-Pacific
      1. China
      2. India
      3. Japan
    5. Latin America
      1. Brazil
    6. Middle East & Africa
  6. Company Profiles
    1. AstraZeneca, Bayer AG
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    2. Danaher
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    3. Bristol Myers Squibb
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    4. Eisai Co., Ltd.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    5. Merck & Co.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    6. Novartis AG
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    7. Novocure
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    8. Pfizer Inc.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    9. Hoffmann-La Roche AG
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments

Report Content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL Analysis
  • Value Chain Analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Overview
    • Financials
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecasts from 2017 – 2026
  • Market revenue estimates for therapy type up to 2026
  • Regional market size and forecast up to 2017 - 2026
  • Regional market size and forecast for therapy type up to 2026
  • Company financials

Request For customization

 

By using this form you agree with the storage and handling of your data by this website.

Speak to Analyst

 

By using this form you agree with the storage and handling of your data by this website.

Inquire Before Buying

 

By using this form you agree with the storage and handling of your data by this website.

Request for Sample


By using this form you agree with the storage and handling of your data by this website.